217 related articles for article (PubMed ID: 18046427)
1. How not to be seen: immune-evasion strategies in gene therapy.
Zaldumbide A; Hoeben RC
Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427
[TBL] [Abstract][Full Text] [Related]
2. Challenges and strategies: the immune responses in gene therapy.
Zhou HS; Liu DP; Liang CC
Med Res Rev; 2004 Nov; 24(6):748-61. PubMed ID: 15250039
[TBL] [Abstract][Full Text] [Related]
3. Innate immune response induced by gene delivery vectors.
Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
[TBL] [Abstract][Full Text] [Related]
4. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
5. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
Jooss K; Chirmule N
Gene Ther; 2003 Jun; 10(11):955-63. PubMed ID: 12756416
[TBL] [Abstract][Full Text] [Related]
6. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
Bessis N; GarciaCozar FJ; Boissier MC
Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
[TBL] [Abstract][Full Text] [Related]
8. Immune barriers to successful gene therapy.
Wu TL; Ertl HC
Trends Mol Med; 2009 Jan; 15(1):32-9. PubMed ID: 19101205
[TBL] [Abstract][Full Text] [Related]
9. Antivector and antitransgene host responses in gene therapy.
Hackett NR; Kaminsky SM; Sondhi D; Crystal RG
Curr Opin Mol Ther; 2000 Aug; 2(4):376-82. PubMed ID: 11249767
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
11. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
Schagen FH; Ossevoort M; Toes RE; Hoeben RC
Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159
[TBL] [Abstract][Full Text] [Related]
12. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
[TBL] [Abstract][Full Text] [Related]
13. Current development of nonviral-mediated gene transfer.
Romano G
Drug News Perspect; 2007 May; 20(4):227-31. PubMed ID: 17637935
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in hepatic gene transfer: more efficacy and less immunogenicity.
Herzog RW
Curr Opin Drug Discov Devel; 2005 Mar; 8(2):199-206. PubMed ID: 15782544
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated gene therapy for retinal disorders: from mouse to man.
Buch PK; Bainbridge JW; Ali RR
Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of cancer: induction of anti-tumor immunity.
Qian C; Prieto J
Cell Mol Immunol; 2004 Apr; 1(2):105-11. PubMed ID: 16212896
[TBL] [Abstract][Full Text] [Related]
17. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for renal diseases.
Lien YH; Lai LW
Kidney Int Suppl; 1997 Oct; 61():S85-8. PubMed ID: 9328975
[TBL] [Abstract][Full Text] [Related]
19. Factoring nonviral gene therapy into a cure for hemophilia A.
Gabrovsky V; Calos MP
Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy with poxvirus vectors.
Moroziewicz D; Kaufman HL
Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
